Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.060EUR
64.60 MEUR
118.69 MEUR
345.61 M
About KANGJI MEDICAL HLDGS LTD
Sector
Industry
CEO
Ming Zhong
Website
Headquarters
Hangzhou
Founded
2004
FIGI
BBG00WCN3VF7
Kangji Medical Holdings Ltd. engages in manufacturing invasive surgical instruments and accessories. It operates through the Mainland China and Other geographical segments. The firm's products include disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and reusable trocar, and forceps. The company was founded by Ming Zhong and Yinguang Shentu in August 2004 and is headquartered in Hangzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange KANGJI MED.HLDS DL-,00001 stocks are traded under the ticker 50J.
We've gathered analysts' opinions on KANGJI MED.HLDS DL-,00001 future price: according to them, 50J price has a max estimate of 1.21 EUR and a min estimate of 0.87 EUR. Watch 50J chart and read a more detailed KANGJI MED.HLDS DL-,00001 stock forecast: see what analysts think of KANGJI MED.HLDS DL-,00001 and suggest that you do with its stocks.
Yes, you can track KANGJI MED.HLDS DL-,00001 financials in yearly and quarterly reports right on TradingView.
KANGJI MED.HLDS DL-,00001 is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
50J earnings for the last half-year are 0.03 EUR per share, whereas the estimation was 0.03 EUR, resulting in a −2.44% surprise. The estimated earnings for the next half-year are 0.03 EUR per share. See more details about KANGJI MED.HLDS DL-,00001 earnings.
KANGJI MED.HLDS DL-,00001 revenue for the last half-year amounts to 58.87 M EUR, despite the estimated figure of 58.60 M EUR. In the next half-year revenue is expected to reach 79.21 M EUR.
50J net income for the last half-year is 37.02 M EUR, while the previous report showed 31.15 M EUR of net income which accounts for 18.86% change. Track more KANGJI MED.HLDS DL-,00001 financial stats to get the full picture.
KANGJI MED.HLDS DL-,00001 dividend yield was 15.57% in 2023, and payout ratio reached 228.57%. The year before the numbers were 2.53% and 44.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has 1.00 K employees. See our rating of the largest employees — is KANGJI MED.HLDS DL-,00001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KANGJI MED.HLDS DL-,00001 EBITDA is 67.51 M EUR, and current EBITDA margin is 51.34%. See more stats in KANGJI MED.HLDS DL-,00001 financial statements.
Like other stocks, 50J shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KANGJI MED.HLDS DL-,00001 stock right from TradingView charts — choose your broker and connect to your account.